Comets E - Search Results

1

Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS).

Hendrickx N, Mentré F, Traschütz A, Gagnon C, Schüle R; ARCA Study Group; EVIDENCE-R. N. D. consortium; Synofzik M, Comets E. Hendrickx N, et al. Among authors: comets e. AAPS J. 2024 Apr 30;26(3):57. doi: 10.1208/s12248-024-00925-7. AAPS J. 2024. PMID: 38689016

2

Association of an IRF5 gene functional polymorphism with Sjögren's syndrome.

Miceli-Richard C, Comets E, Loiseau P, Puechal X, Hachulla E, Mariette X. Miceli-Richard C, et al. Among authors: comets e. Arthritis Rheum. 2007 Dec;56(12):3989-94. doi: 10.1002/art.23142. Arthritis Rheum. 2007. PMID: 18050197 Free PMC article.

3

An in vivo pharmacokinetic/pharmacodynamic model for antiretroviral combination.

Legrand M, Comets E, Aymard G, Tubiana R, Katlama C, Diquet B. Legrand M, et al. Among authors: comets e. HIV Clin Trials. 2003 May-Jun;4(3):170-83. doi: 10.1310/77yn-gdmu-95w3-rwt7. HIV Clin Trials. 2003. PMID: 12815557 Clinical Trial.

4

Evaluation of tests based on individual versus population modeling to compare dissolution curves.

Comets E, Mentré F. Comets E, et al. J Biopharm Stat. 2001;11(3):107-23. doi: 10.1081/BIP-100107652. J Biopharm Stat. 2001. PMID: 11725926

5

Population pharmacodynamic analysis of octreotide in acromegalic patients.

Comets E, Mentré F, Grass P, Kawai R, Marbach P, Vonderscher J. Comets E, et al. Clin Pharmacol Ther. 2003 Jan;73(1):95-106. doi: 10.1067/mcp.2003.6. Clin Pharmacol Ther. 2003. PMID: 12545148

6

Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide.

Brendel K, Comets E, Laffont C, Laveille C, Mentré F. Brendel K, et al. Among authors: comets e. Pharm Res. 2006 Sep;23(9):2036-49. doi: 10.1007/s11095-006-9067-5. Epub 2006 Aug 12. Pharm Res. 2006. PMID: 16906454 Free PMC article.

7

Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters.

Comets E, Verstuyft C, Lavielle M, Jaillon P, Becquemont L, Mentré F. Comets E, et al. Eur J Clin Pharmacol. 2007 May;63(5):437-49. doi: 10.1007/s00228-007-0269-5. Epub 2007 Mar 13. Eur J Clin Pharmacol. 2007. PMID: 17404720 Free PMC article.

8

Design in nonlinear mixed effects models: optimization using the Fedorov-Wynn algorithm and power of the Wald test for binary covariates.

Retout S, Comets E, Samson A, Mentré F. Retout S, et al. Among authors: comets e. Stat Med. 2007 Dec 10;26(28):5162-79. doi: 10.1002/sim.2910. Stat Med. 2007. PMID: 17486667

9

Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.

Comets E, Brendel K, Mentré F. Comets E, et al. Comput Methods Programs Biomed. 2008 May;90(2):154-66. doi: 10.1016/j.cmpb.2007.12.002. Epub 2008 Jan 22. Comput Methods Programs Biomed. 2008. PMID: 18215437 Free article.

10

Comparison of model-based tests and selection strategies to detect genetic polymorphisms influencing pharmacokinetic parameters.

Bertrand J, Comets E, Mentre F. Bertrand J, et al. Among authors: comets e. J Biopharm Stat. 2008;18(6):1084-102. doi: 10.1080/10543400802369012. J Biopharm Stat. 2008. PMID: 18991109 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters